Antiplatelet and antithrombotic activities of salvianolic acid A

Fuster, 1985, Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death, JAM Coll Cardiol, 175B, 10.1016/S0735-1097(85)80552-0 Packham, 1986, The role of platelets in the development and complication of atherosclerosis, Semin Hematol, 23, 8 Ruggeri, 1997, Mechanisms initiating platelet thrombus formation, Thromb Haemost, 78, 611, 10.1055/s-0038-1657598 Banno, 1999, Antiaggregatory, antithrombotic effects of MS-180, a novel platelet glycoprotein IIb/IIIa receptor antagonist, Eur J Pharmacol, 367, 275, 10.1016/S0014-2999(98)00937-6 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 De Meyer, 2008, Antiplatelet drugs, Brit J Haematol, 142, 515, 10.1111/j.1365-2141.2008.07233.x Yun-Choi, 2001, Antithrombotic effects of YS-49 and YS-51—1-Naphthylmethyl analogs of higenamine, Thromb Res, 104, 249, 10.1016/S0049-3848(01)00372-3 Cheng, 2007, Cardiovascular effects of Danshen, Int J Cardiol, 121, 9, 10.1016/j.ijcard.2007.01.004 Cheng, 2006, Danshen: A versatile Chinese herbal drug for the treatment of coronary heart disease, Int J Cardiol, 113, 437, 10.1016/j.ijcard.2005.10.026 Cheng, 2006, Danshen: What every cardiologist should know about this Chinese herbal drug, Int J Cardiol, 110, 411, 10.1016/j.ijcard.2005.08.069 Liu, 1992, Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes, Biochem Pharmacol, 43, 147, 10.1016/0006-2952(92)90271-J Shang, 2007, Protective effects of salvianolic acid A on focal cerebral ischemia in rats, J Pharm Clin Tradit Chin Med, 23, 15 Qi, 1996, 522 Chang, 1997, Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl) amino]-3-chloro-1, 4-naphthalenedione (NQ-Y15) in rat platelets, Biochem Pharmacol, 54, 259, 10.1016/S0006-2952(97)00179-2 Born, 1964, Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate, J Physiol, 170, 394, 10.1113/jphysiol.1964.sp007340 Walsh, 1977, Metabolism and function of human platelets washed by albumin density gradient separation, Brit J Haematol, 36, 281, 10.1111/j.1365-2141.1977.tb00649.x Umar, 2004, Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model, Fund Clin Pharmacol, 18, 559, 10.1111/j.1472-8206.2004.00285.x Umar, 2003, Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo, Thromb Res, 110, 135, 10.1016/S0049-3848(03)00343-8 Chen, 2007, Effect of ethanol extract of terminalia chebula on microrheological characteristics in acute blood stasis model rat, Chin J Hemorh, 17, 525 Gao, 2004, Pharmacokinetics and pharmacodynamics research on salvianolic acid B in the healthy volunteers, Chin J Clin Pharmacol Ther, 11, 1209 Gao, 2007, Effect of salvianolic acid B on the platelet aggregation and adhesiveness in healthy volunteers, J Bengbu Med Coll, 32, 514 Jackson, 2003, Signaling events underlying thrombus formation, J Thromb Haemost, 1, 1602, 10.1046/j.1538-7836.2003.00267.x Farndale, 2004, The role of collagen in thrombosis and hemostasis, J Thromb Haemost, 2, 561, 10.1111/j.1538-7836.2004.00665.x Lee, 2006, Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor, Pharmacol Res, 53, 265, 10.1016/j.phrs.2005.12.003 Kahner, 2006, Nucleotide receptor signaling in platelets, J Thromb Haemost, 4, 2317, 10.1111/j.1538-7836.2006.02192.x Andre, 2003, P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries, J Clin Invest, 112, 398, 10.1172/JCI17864 Hsiao, 2004, Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies, Eur J Pharmacol, 487, 159, 10.1016/j.ejphar.2004.01.026 Zhang, 2001, Antiplatelet effect of 2-Chloro-3-(4-acetophenyl)-amino-1, 4-naphthoquinone (NQ301): A possible mechanism through inhibition of intracellular Ca2+ mobilization, Biol Pharm Bull, 24, 618, 10.1248/bpb.24.618 Smith, 1982, Fibrin, red cell and platelet interactions in an experimental model of thrombosis, Br J Pharmacol, 77, 29, 10.1111/j.1476-5381.1982.tb09265.x Damiano, 2001, Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist, Thromb Res, 104, 113, 10.1016/S0049-3848(01)00353-X Baskurt, 2003, Blood Rheology and Hemodynamics, Semin Thromb Hemost, 29, 435, 10.1055/s-2003-44551 Jan, 1975, Observations on blood viscosity changes after acute myocardial infarction, Circulation, 51, 1079, 10.1161/01.CIR.51.6.1079 Lowe, 1997, Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study, Brit J Haematol, 96, 168, 10.1046/j.1365-2141.1997.8532481.x Grotta, 1982, Whole blood viscosity parameters and cerebral blood flow, Stroke, 13, 296, 10.1161/01.STR.13.3.296 Muldoon, 1995, Effects of acute psychological stress on serum lipid levels, hemoconcentration, and blood viscosity, Arch Intern Med, 155, 615, 10.1001/archinte.1995.00430060077009